The first West Pharmaceutical Services trade was made in Q3 2020.
Since then Ray Dalio bought shares six more times and sold shares on nine occasions. The investor completely sold their stake between Q4 2022 and Q2 2024.
Avg closing price
Price range
Sold -1.29k shares
Q2 2024
Avg closing price
$353.40
Price range
$314.68
-
$395.94
Sold 70.6% shares (-3.1k shares)
Q1 2024
Avg closing price
$369.91
Price range
$338.27
-
$413.00
Sold 5.6% shares (-262 shares)
Q4 2023
Avg closing price
$353.90
Price range
$318.29
-
$392.21
Sold 5.7% shares (-280 shares)
Q3 2023
Avg closing price
$386.88
Price range
$354.90
-
$412.41
Sold 0.6% shares (-30 shares)
Q2 2023
Avg closing price
$357.24
Price range
$334.63
-
$382.47
Sold 59.4% shares (-7.25k shares)
Q1 2023
Avg closing price
$292.19
Price range
$232.50
-
$346.47
Sold 71.0% shares (-29.9k shares)
Q4 2022
Avg closing price
$236.96
Price range
$209.34
-
$261.61
Increased shares by 81.7% (+18.9k shares)
Q3 2022
Avg closing price
$304.64
Price range
$246.08
-
$343.65
Increased shares by 112.6% (+12.3k shares)
Q2 2022
Avg closing price
$325.39
Price range
$280.61
-
$420.45
Increased shares by 30.2% (+2.53k shares)
Q1 2022
Avg closing price
$391.48
Price range
$357.49
-
$445.92
Sold 90.1% shares (-75.7k shares)
Q4 2021
Avg closing price
$430.44
Price range
$402.25
-
$471.34
Sold 4.0% shares (-3.5k shares)
Q3 2021
Avg closing price
$421.55
Price range
$363.01
-
$468.47
Increased shares by 80.6% (+39.1k shares)
Q2 2021
Avg closing price
$330.40
Price range
$284.77
-
$363.20
Increased shares by 14.5% (+6.13k shares)
Q1 2021
Avg closing price
$286.20
Price range
$257.29
-
$307.53
Increased shares by 140.1% (+24.7k shares)
Q4 2020